/Companies

Antheia, Inc.

Menlo Park, US · Founded 2013 · Delaware corporation · 67 employees on LinkedIn · 9 known investors

Find your way into Antheia, Inc.

Sign up to see every warm intro you have to Antheia, Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Antheia, Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing. The company targets pharmaceutical supply chains, aiming to reduce drug shortages and improve reliability for medicines traditionally derived from plants.

Founders & leadership

Antheia, Inc. was founded in 2013 by Christina Smolke and Kristy Hawkins.

CSChristina Smolke
Christina SmolkeFounder
KHKristy Hawkins
Kristy HawkinsFounderKristy Hawkins is a co-founder and Chief Science Officer of Antheia, bringing over 15 years of experience in synthetic biology and yeast metabolic engineering for small molecule production. Her expertise spans tool development, high-throughput screening, and pathway engineering applied to fermentation-based pharmaceutical manufacturing.
EDEric d'Esparbes
Eric d'EsparbesChief Financial OfficerEric d'Esparbes is Chief Financial Officer of Antheia, a biomanufacturing company producing pharmaceutical ingredients through fermentation. He brings extensive experience in financial leadership at public and private biopharmaceutical companies, including interim CEO roles, with demonstrated expertise in capital raising, P&L management across billions in revenue, and regulatory compliance in pharmaceutical and diagnostics sectors.
ZMZack McGahey
Zack McGaheyChief Operating OfficerZack McGahey holds a BS in Bioengineering from UC Berkeley and an MBA from Wharton. He has over 20 years of experience in manufacturing and operations, with prior roles including Director of Manufacturing Facilities at Tesla, Vice President of Manufacturing at Zymergen, and Head of Manufacturing at Grifols Diagnostic Solutions, and is currently Chief Operating Officer of Antheia.
HPHeidi Pucel
Heidi PucelChief People OfficerHeidi Pucel is Chief People Officer at Antheia. She has worked across human resources functions including training, employee relations, mergers and acquisitions, recruiting, compensation and benefits, and strategic planning.

Board

RSRam Shriram
Ram ShriramBoard directorManaging Partner at Sherpalo Ventures
CT
Catherine ThodeyBoard director

Investors · 9

Also in the syndicate · 2

ATHOS KGleadEDBI

Funding

SEC filings, press & company announcements

$97.4M disclosed across 5 rounds · 2015–2026

▶$9.2MraisedSep 2018 · 5 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ram ShriramDirector
  • Valerie MinassianExecutive Officer
  • Catherine ThodeyDirector
  • Christina D. SmolkeExecutive Officer, Director
Offering amount
$15.5M
Amount sold
$9.2M
First sale
Aug 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.2MraisedMay 2017 · 4 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Catherine ThodeyDirector
  • Christina D. SmolkeExecutive Officer, Director
  • Ram ShriramDirector
Offering amount
$25M
Amount sold
$6.2M
First sale
May 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMar 2015 · 10 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ram ShriramDirector
  • Catherine ThodeyDirector
  • Christina D. SmolkeExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$2M
First sale
Mar 2015
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Antheia, Inc. went on to found or lead other companies.

In the news

Frequently asked questions

What does Antheia, Inc. do?
Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing. The company targets pharmaceutical supply chains, aiming to reduce drug shortages and improve reliability for medicines traditionally derived from plants.
Who founded Antheia, Inc.?
Antheia, Inc. was founded by Christina Smolke, Kristy Hawkins in 2013.
Who are Antheia, Inc.'s investors?
Antheia, Inc.'s investors include America's Frontier Fund, Civilization Ventures Management, Llc, Global Health Investment Corporation, In-Q-Tel, Lam Capital, Sherpalo Ventures, Western Technology Investment.
How much funding has Antheia, Inc. raised?
Antheia, Inc. has disclosed $97.4M raised across 5 rounds.
Where is Antheia, Inc. headquartered?
Antheia, Inc. is headquartered in Menlo Park, US.